{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:40:39Z","timestamp":1790116839591,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2017YFA0105104"],"award-info":[{"award-number":["2017YFA0105104"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The R1441G mutation in the leucine-rich repeat kinase 2 (LRRK2) gene results in late-onset Parkinson\u2019s disease (PD). Peripheral inflammation and gut microbiota are closely associated with the pathogenesis of PD. Chronic periodontitis is a common type of peripheral inflammation, which is associated with PD.\n                      <jats:italic>Porphyromonas gingivalis<\/jats:italic>\n                      (Pg), the most common bacterium causing chronic periodontitis, can cause alteration of gut microbiota. It is not known whether Pg-induced dysbiosis plays a role in the pathophysiology of PD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, live Pg were orally administrated to animals, three times a week for 1 month. Pg-derived lipopolysaccharide (LPS) was used to stimulate mononuclear cells in vitro. The effects of oral Pg administration on the gut and brain were evaluated through behaviors, morphology, and cytokine expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Dopaminergic neurons in the substantia nigra were reduced, and activated microglial cells were increased in R1441G mice given oral Pg. In addition, an increase in mRNA expression of tumor necrosis factor (TNF-\u03b1) and interleukin-1\u03b2 (IL-1\u03b2) as well as protein level of \u03b1-synuclein together with a decrease in zonula occludens-1 (Zo-1) was detected in the colon in Pg-treated R1441G mice. Furthermore, serum interleukin-17A (IL-17A) and brain IL-17 receptor A (IL-17RA) were increased in Pg-treated R1441G mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that oral Pg-induced inflammation may play an important role in the pathophysiology of LRRK2-associated PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-020-02027-5","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T06:02:56Z","timestamp":1605765776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice"],"prefix":"10.1186","volume":"17","author":[{"given":"Yu-Kun","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Wen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Yin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Jing","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"issue":"2","key":"2027_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrneurol.2015.249","volume":"12","author":"LV Kalia","year":"2016","unstructured":"Kalia LV, Lang AE. Parkinson disease in 2015: evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol. 2016;12(2):65\u20136.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2027_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","volume":"52","author":"D MacLeod","year":"2006","unstructured":"MacLeod D, Dowman J, Hammond R, et al. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron. 2006;52(4):587\u201393.","journal-title":"Neuron"},{"issue":"Pt 12","key":"2027_CR3","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1093\/brain\/awh667","volume":"128","author":"NL Khan","year":"2005","unstructured":"Khan NL, Jain S, Lynch JM, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson\u2019s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain. 2005;128(Pt 12):2786\u201396.","journal-title":"Brain"},{"issue":"3","key":"2027_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/archneur.63.3.377","volume":"63","author":"C Gaig","year":"2006","unstructured":"Gaig C, Ezquerra M, Marti MJ, et al. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol. 2006;63(3):377\u201382.","journal-title":"Arch Neurol"},{"issue":"1","key":"2027_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/BST20160262","volume":"45","author":"H Lee","year":"2017","unstructured":"Lee H, James WS, Cowley SA. LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson\u2019s disease. Biochem Soc Trans. 2017;45(1):131\u20139.","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"2027_CR6","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awy077","volume":"141","author":"E Kozina","year":"2018","unstructured":"Kozina E, Sadasivan S, Jiao Y, et al. Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. Brain. 2018;141(6):1753\u201369.","journal-title":"Brain"},{"issue":"2","key":"2027_CR7","doi-asserted-by":"publisher","first-page":"e4412","DOI":"10.1371\/journal.pntd.0004412","volume":"10","author":"VM Fava","year":"2016","unstructured":"Fava VM, Manry J, Cobat A, et al. A missense LRRK2 variant is a risk factor for excessive inflammatory responses in leprosy. PLoS Negl Trop Dis. 2016;10(2):e4412.","journal-title":"PLoS Negl Trop Dis"},{"key":"2027_CR8","doi-asserted-by":"crossref","unstructured":"Takagawa T, Kitani A, Fuss I, et al. An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitis. Sci Transl Med. 2018;10(444):eaan8162.","DOI":"10.1126\/scitranslmed.aan8162"},{"issue":"10","key":"2027_CR9","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1084\/jem.20170014","volume":"214","author":"W Liu","year":"2017","unstructured":"Liu W, Liu X, Li Y, et al. LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection. J Exp Med. 2017;214(10):3051\u201366.","journal-title":"J Exp Med"},{"key":"2027_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2014.04.021","volume":"68","author":"JS Chou","year":"2014","unstructured":"Chou JS, Chen CY, Chen YL, et al. (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse. Neurobiol Dis. 2014;68:190\u20139.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2027_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/ger.12188","volume":"33","author":"T Kaur","year":"2016","unstructured":"Kaur T, Uppoor A, Naik D. Parkinson\u2019s disease and periodontitis - the missing link? A review. Gerodontology. 2016;33(4):434\u20138.","journal-title":"Gerodontology"},{"issue":"10","key":"2027_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jocn.2008.12.027","volume":"16","author":"A Hanaoka","year":"2009","unstructured":"Hanaoka A, Kashihara K. Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson\u2019s disease. J Clin Neurosci. 2009;16(10):1279\u201382.","journal-title":"J Clin Neurosci"},{"key":"2027_CR13","doi-asserted-by":"crossref","unstructured":"Einarsdottir ER, Gunnsteinsdottir H, Hallsdottir MH, et al. Dental health of patients with Parkinson\u2019s disease in Iceland. Spec Care Dentist. 2009;29(3):123\u20137.","DOI":"10.1111\/j.1754-4505.2009.00075.x"},{"issue":"7","key":"2027_CR14","first-page":"e134234","volume":"10","author":"M Nakajima","year":"2015","unstructured":"Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS One. 2015;10(7):e134234.","journal-title":"PLoS One"},{"key":"2027_CR15","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1038\/srep04828","volume":"4","author":"K Arimatsu","year":"2014","unstructured":"Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep. 2014;4:4828.","journal-title":"Sci Rep"},{"key":"2027_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? NPJ Parkinsons Dis. 2017;3:3.","journal-title":"NPJ Parkinsons Dis"},{"issue":"167","key":"2027_CR17","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"6","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell. 2016;6(167):1469\u201380..","journal-title":"Cell"},{"key":"2027_CR18","doi-asserted-by":"crossref","unstructured":"Olsen I, Kell DB, Pretorius E. Is Porphyromonas gingivalis involved in Parkinson\u2019s disease? Eur J Clin Microbiol Infect Dis. 2020.","DOI":"10.1007\/s10096-020-03944-2"},{"key":"2027_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fnagi.2019.00210","volume":"11","author":"B Adams","year":"2019","unstructured":"Adams B, Nunes JM, Page MJ, et al. Parkinson\u2019s disease: a systemic inflammatory disease accompanied by bacterial inflammagens. Front Aging Neurosci. 2019;11:210.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"2027_CR20","first-page":"567","volume":"30","author":"Y Huang","year":"2014","unstructured":"Huang Y, Liu Z, Wang XQ, et al. A dysfunction of CD4+ T lymphocytes in peripheral immune system of Parkinson\u2019s disease model mice. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2014;30(6):567\u201376.","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"1","key":"2027_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, Maxreiter F, Krach F, et al. Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson\u2019s disease. Cell Stem Cell. 2018;23(1):123\u201331.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2027_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/JPD-191699","volume":"9","author":"HF Green","year":"2019","unstructured":"Green HF, Khosousi S, Svenningsson P. Plasma IL-6 and IL-17A correlate with severity of motor and non-motor symptoms in Parkinson\u2019s disease. J Parkinsons Dis. 2019;9(4):705\u20139.","journal-title":"J Parkinsons Dis"},{"key":"2027_CR23","first-page":"2979846","volume":"2016","author":"LP Borilova","year":"2016","unstructured":"Borilova LP, Kastovsky J, S. Lucanovaet al. Interleukin-17A gene variability in patients with type 1 diabetes mellitus and chronic periodontitis: its correlation with IL-17 levels and the occurrence of periodontopathic bacteria. Mediators Inflamm. 2016;2016:2979846.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"2027_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1600-0765.2011.01464.x","volume":"47","author":"M Adibrad","year":"2012","unstructured":"Adibrad M, Deyhimi P, Ganjalikhani HM, et al. Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res. 2012;47(4):525\u201331.","journal-title":"J Periodontal Res"},{"issue":"2","key":"2027_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10875-010-9368-7","volume":"30","author":"C Blaschitz","year":"2010","unstructured":"Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol. 2010;30(2):196\u2013203.","journal-title":"J Clin Immunol"},{"issue":"2","key":"2027_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis. 2006;21(2):404\u201312.","journal-title":"Neurobiol Dis"},{"issue":"1-2","key":"2027_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jneuroim.2013.05.001","volume":"261","author":"C Barcia","year":"2013","unstructured":"Barcia C, Ros CM, Ros-Bernal F, et al. Persistent phagocytic characteristics of microglia in the substantia nigra of long-term Parkinsonian macaques. J Neuroimmunol. 2013;261(1-2):60\u20136.","journal-title":"J Neuroimmunol"},{"key":"2027_CR28","doi-asserted-by":"crossref","unstructured":"Ma Y, Zheng C, Shi L. The kinase LRRK2 is differently expressed in chronic rhinosinusitis with and without nasal polyps. Clin Transl Allergy. 2018;8(1).","DOI":"10.1186\/s13601-018-0194-y"},{"issue":"6","key":"2027_CR29","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1007\/s12035-016-9988-x","volume":"54","author":"A Stojakovic","year":"2017","unstructured":"Stojakovic A, Paz-Filho G, Arcos-Burgos M, et al. Role of the IL-1 pathway in dopaminergic neurodegeneration and decreased voluntary movement. Mol Neurobiol. 2017;54(6):4486\u201395.","journal-title":"Mol Neurobiol"},{"issue":"Pt 7","key":"2027_CR30","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/brain\/awn101","volume":"131","author":"GMC Pott","year":"2008","unstructured":"Pott GMC, Tarelli R, Ferrari CC, et al. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson\u2019s disease. Brain. 2008;131(Pt 7):1880\u201394.","journal-title":"Brain"},{"key":"2027_CR31","doi-asserted-by":"crossref","unstructured":"M. P. Mount, A. Lira, D. Grimeset al. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci, 2007, 27(12):3328-3337.","DOI":"10.1523\/JNEUROSCI.5321-06.2007"},{"key":"2027_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.biopha.2018.05.072","volume":"104","author":"L Li","year":"2018","unstructured":"Li L, Wan G, Han B, et al. Echinacoside alleviated LPS-induced cell apoptosis and inflammation in rat intestine epithelial cells by inhibiting the mTOR\/STAT3 pathway. Biomed Pharmacother. 2018;104:622\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2027_CR33","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1177\/0022034519869580","volume":"98","author":"HS Wang","year":"2019","unstructured":"Wang HS, Yang FH, Wang YJ, et al. Odontoblastic exosomes attenuate apoptosis in neighboring cells. J Dent Res. 2019;98(11):1271\u20138.","journal-title":"J Dent Res"},{"issue":"3","key":"2027_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12017-019-08539-5","volume":"21","author":"Yuki Kishimoto","year":"2019","unstructured":"Yuki Kishimoto, Wandi Zhu, Waki Hosoda et al. Chronic mild gut inflammation accelerates brain neuropathology and motor dysfunction in \u03b1 - synuclein mutant mice. Neuromolecular Med. 2019;21(3):239\u201349.","journal-title":"Neuromolecular Med."},{"issue":"5","key":"2027_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00702-011-0653-2","volume":"118","author":"M Hakimi","year":"2011","unstructured":"Hakimi M, Selvanantham T, Swinton E, et al. Parkinson\u2019s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. J Neural Transm (Vienna). 2011;118(5):795\u2013808.","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"2027_CR36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/ni.2113","volume":"12","author":"Z Liu","year":"2011","unstructured":"Liu Z, Lee J, Krummey S, et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol. 2011;12(11):1063\u201370.","journal-title":"Nat Immunol"},{"issue":"8","key":"2027_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/mds.25736","volume":"29","author":"LP Kelly","year":"2014","unstructured":"Kelly LP, Carvey PM, Keshavarzian A, et al. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease. Mov Disord. 2014;29(8):999\u20131009.","journal-title":"Mov Disord"},{"key":"2027_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? NPJ Parkinsons Dis. 2017;3:3.","journal-title":"NPJ Parkinsons Dis"},{"issue":"28","key":"2027_CR39","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","volume":"36","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA, Abdelmotilib H, Liu Z, et al. G2019S-LRRK2 expression augments alpha-synuclein sequestration into inclusions in neurons. J Neurosci. 2016;36(28):7415\u201327.","journal-title":"J Neurosci"},{"key":"2027_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-319-49969-7_11","volume":"14","author":"JP Daher","year":"2017","unstructured":"Daher JP. Interaction of LRRK2 and alpha-synuclein in Parkinson\u2019s disease. Adv Neurobiol. 2017;14:209\u201326.","journal-title":"Adv Neurobiol"},{"issue":"4","key":"2027_CR41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103(4):627\u201341.","journal-title":"Neuron"},{"issue":"1","key":"2027_CR42","first-page":"117","volume":"29","author":"M Maes","year":"2008","unstructured":"Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008;29(1):117\u201324.","journal-title":"Neuro Endocrinol Lett"},{"issue":"Suppl 11","key":"2027_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1600-051X.2010.01671.x","volume":"38","author":"PM Preshaw","year":"2011","unstructured":"Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011;38(Suppl 11):60\u201384.","journal-title":"J Clin Periodontol"},{"issue":"3","key":"2027_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1600-051X.2011.01784.x","volume":"39","author":"I Tomas","year":"2012","unstructured":"Tomas I, Diz P, Tobias A, et al. Periodontal health status and bacteraemia from daily oral activities: systematic review\/meta-analysis. J Clin Periodontol. 2012;39(3):213\u201328.","journal-title":"J Clin Periodontol"},{"issue":"5","key":"2027_CR45","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/gutjnl-2015-309897","volume":"66","author":"V Blasco-Baque","year":"2017","unstructured":"Blasco-Baque V, Garidou L, Pomie C, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut. 2017;66(5):872\u201385.","journal-title":"Gut"},{"issue":"5","key":"2027_CR46","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.2569","volume":"14","author":"DA Bermejo","year":"2013","unstructured":"Bermejo DA, Jackson SW, Gorosito-Serran M, et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat Immunol. 2013;14(5):514\u201322.","journal-title":"Nat Immunol"},{"issue":"1","key":"2027_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI63681","volume":"123","author":"M Huber","year":"2013","unstructured":"Huber M, Heink S, Pagenstecher A, et al. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest. 2013;123(1):247\u201360.","journal-title":"J Clin Invest"},{"issue":"4","key":"2027_CR48","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/imm.12993","volume":"155","author":"A Akitsu","year":"2018","unstructured":"Akitsu A, Iwakura Y. Interleukin-17-producing gammadelta T (gammadelta17) cells in inflammatory diseases. Immunology. 2018;155(4):418\u201326.","journal-title":"Immunology"},{"key":"2027_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-015-0394-5","volume":"12","author":"J Sun","year":"2015","unstructured":"Sun J, Zhang S, Zhang X, et al. IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation. J Neuroinflammation. 2015;12:165.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"2027_CR50","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","volume":"129","author":"A Waisman","year":"2015","unstructured":"Waisman A, Hauptmann J, Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015;129(5):625\u201337.","journal-title":"Acta Neuropathol"},{"key":"2027_CR51","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","volume":"81","author":"Z Liu","year":"2019","unstructured":"Liu Z, Qiu AW. Y. Huanget al. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease. Brain Behav Immun. 2019;81:630\u201345.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"2027_CR52","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007;13(10):1173\u20135.","journal-title":"Nat Med"},{"issue":"4","key":"2027_CR53","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","volume":"181","author":"F Jill","year":"2008","unstructured":"Jill F. Wright, Frann Bennett, Bilian Liet al. The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex. J Immunol. 2008;181(4):2799\u2013805.","journal-title":"J Immunol"},{"issue":"4","key":"2027_CR54","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1189\/jlb.0208108","volume":"84","author":"RN Dilger","year":"2008","unstructured":"Dilger RN, Johnson RW. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol. 2008;84(4):932\u20139.","journal-title":"J Leukoc Biol"},{"issue":"23","key":"2027_CR55","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1093\/hmg\/ddu341","volume":"23","author":"T Li","year":"2014","unstructured":"Li T, Yang D, Zhong S, et al. Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson\u2019s disease cell and mouse models. Hum Mol Genet. 2014;23(23):6212\u201322.","journal-title":"Hum Mol Genet"},{"key":"2027_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","volume":"208","author":"F Gillardon","year":"2012","unstructured":"Gillardon F, Schmid R, Draheim H. Parkinson\u2019s disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity. Neuroscience. 2012;208:41\u20138.","journal-title":"Neuroscience"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-02027-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-020-02027-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-020-02027-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T06:03:36Z","timestamp":1605765816000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-020-02027-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2027"],"URL":"https:\/\/doi.org\/10.1186\/s12974-020-02027-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-34883\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All protocols were performed according to the Guide for the Care and Use of Laboratory Animals of Sun Yat-sen University (Guangzhou, China) Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}